|
TW201637651A
|
|
Controlled release pharmaceutical composition and method for manufacturing the same
|
|
US2015224159A1
|
|
Extracts of perilla frutescens seeds and their pharmaceutical uses
|
|
TW201519848A
|
|
Illumination system for endoscopic examinations
|
|
US2015306167A1
|
|
Alpinia spp. extracts for treating irritable bowel syndrome
|
|
CN104780928A
|
|
Use of tatarian aster extract in preparing medicament for treating pain
|
|
TWI458503B
|
|
Vitamin k2 microsphere, manufacture method, use, and drug thereof
|
|
CN102552357A
|
|
Use of Aster extract in the treatment of opioid-induced constipation
|
|
CN101836977A
|
|
Extract of Morus australis Poir. and antibacterial application of Kuwanon H compound
|
|
TW201023870A
|
|
Anti-bacterial use of extract from morus australis poir. and compound kuwanon h.
|
|
TW201023869A
|
|
Antitussive agent and manufacture thereof
|
|
TW200918085A
|
|
Use of a potent product extracted from rhizomes of zingiber officinale in treating a disease associated with helicobacter pylori
|
|
US2009104293A1
|
|
Use of a potent product extracted from rhizomes of Zingiber officinale in treating a disease associated with Helicobacter pylori
|
|
GB0720168D0
|
|
Use of a potent product extracted from rhizomes of zingiber officinale in treating a disease associated with helicobacter pylori
|
|
GB0718678D0
|
|
Uses of 2-[piperidinyl]methy1-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect
|
|
TW200909008A
|
|
Porous dressing
|
|
TW200906422A
|
|
Compound dressing
|
|
US2008076724A1
|
|
Polygalatenosides and use thereof as an antidepressant agent
|
|
TW200603840A
|
|
Bioadhesive dosage form of steroids
|
|
TW200534866A
|
|
Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods thereof
|
|
TW200529889A
|
|
Pharmaceutical composition of rapidly dissolving tablet and method of fabricating the same
|
